Company Overview and News


Add 539268
to your dashboard

Headline News

Steadview Capital sells 19.50 lakh shares of Syngene International

2017-11-24 moneycontrol
On November 23, 2017 Gaoling Fund LP bought 15,00,000 shares of Syngene International at Rs 515 on the BSE.

Syngene International Limited

2017-11-14 thehindubusinessline
Syngene International has expanded its ongoing drug discovery and development operations with its US-based partner Bristol-Myers Squibb till 2026, the company said in a notice to the stock exchanges. The expansion would also include addition of a new facility and ramping up the team of scientists, the statement added. As part of the expansion, it will set up a new dedicated facility spread across 25,000 sq ft of laboratory and office space for Bristol-Myers Squibb. (72-0)

Biocon arm widens partnership terms with Bristol-Myers Squibb

2017-11-14 thehindubusinessline
Biocon’s contract research arm Syngene International has expanded its ongoing drug discovery and development with US-based Bristol-Myers Squibb till 2026. (72-0)

Biocon arm widens partnership terms with Bristol-Myers Squibb

2017-11-14 moneycontrol
Biocon's contract research arm Syngene International has expanded its ongoing drug discovery and development with US-based Bristol-Myers Squibb till 2026. (72-0)

Syngene International Limited - Press Release

2017-11-14 nseindia
The information displayed herein is uploaded by the concerned Company. The said uploaded information is displayed without any verification of adequacy, accuracy and veracity. The Exchange in discharge of its role of dissemination of uploaded information on this website immediately on its receipt. The Company shall be solely responsible and liable for any omission, commission, errors and misrepresentations in the contents of the Information. (15-0)

Syngene International draws up $102 million spending programme

2017-11-05 moneycontrol
Leading contract research & manufacturing organisation Syngene International Ltd said it will invest USD 102 million to build new infrastructure and developing new capabilities.

Syngene International Limited - Investor Presentation

2017-11-03 nseindia
The information displayed herein is uploaded by the concerned Company. The said uploaded information is displayed without any verification of adequacy, accuracy and veracity. The Exchange in discharge of its role of dissemination of uploaded information on this website immediately on its receipt. The Company shall be solely responsible and liable for any omission, commission, errors and misrepresentations in the contents of the Information. (15-0)

Syngene International Limited - Analysts/Institutional Investor Meet/Con. Call Updates

2017-11-03 nseindia
The information displayed herein is uploaded by the concerned Company. The said uploaded information is displayed without any verification of adequacy, accuracy and veracity. The Exchange in discharge of its role of dissemination of uploaded information on this website immediately on its receipt. The Company shall be solely responsible and liable for any omission, commission, errors and misrepresentations in the contents of the Information. (15-0)

Asian markets lower after Dow Jones hits over 22,000 mark

2017-08-03 indiainfoline
Disclaimer: The contents herein is specifically prepared by ‘Dalal Street Investment Journal’, and is for your information & personal consumption only. India Infoline Limited or Dalal Street Investment Journal do not guarantee the accuracy, correctness, completeness or reliability of information contained herein and shall not be held responsible.